Annual report 2025

The fiscal year 2025 was marked by various challenges for Jenoptik, particularly from the semiconductor equipment and automotive markets. Nevertheless, we have continued to focus on our relevant growth potentials in our core markets of semiconductors, medical technology, metrology and smart mobility, and we look to the future with optimism thanks to our strong growth platforms.

Overview over the fiscal year 2025

Jenoptik performed well overall in a challenging market environment in 2025.
Despite a 6 percent decline in revenue, we were able to maintain our profitability at a solid level, with an EBITDA margin of 18.4 percent, thanks to cost-cutting measures implemented early on.
We succeeded in further improving key balance sheet and financial ratios. The Group increased its equity ratio to around 60 percent, and free cash flow before interest and taxes rose by approximately 50 million euros.
The Executive Board and Supervisory Board will propose a dividend distribution of 0.40 euros per share to the Annual General Meeting.
The Group’s organizational structure has been realigned more closely with our growth areas of semiconductor, medical, measurement, and transportation technology.
With the opening of the new factory for innovative micro-optics in Dresden, an important foundation has been laid to realize further growth potential in this area.
Our approach to sustainability: The Executive Board and Supervisory Board are proposing a dividend distribution of €0.38 per share to the Annual General Meeting.
Outlook: We expect to return to a growth trajectory in fiscal year 2026.